Valeria Santini, MD, Associate Professor of Hematology at the University of Florence, Italy, describes how
genetic mutations and
cytogenetics give doctors insight into how
MDS is likely to progress and also serve as potential targets for
targeted MDS therapy. Testing for mutations in specific genes and looking for changes in the overall karyotype, or genetic profile, are both important to learn how MDS may evolve with time and treatment and can help doctors choose the most likely effective therapies.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.